Molecular Quantum Solutions (MQS) is a Copenhagen-based startup founded in 2019 by Mark Nicholas Jones, accelerating pharmaceutical and chemical industries by providing a quantum software platform for calculating thermodynamic properties of molecules. MQS raised €600,000 in pre-seed funding led by Scale Capital, with participation from Rockstart and Stokbro Invest in June 2023. The company’s platform, Cebule, focuses on drug formulation rather than drug discovery, addressing the stage where many drugs actually fail. The MQS Dashboard offers a visual interface to search through quantum chemistry data of over 200 million molecules, with the Cebule Compute Engine, JupyterLab, and Kubeflow integrated to leverage high-performance CPUs, GPUs, and QPUs. MQS converts their tool stack into a software-as-a-service solution for pharmaceutical and chemical industries, disrupting the drug formulation space with quantum chemistry simulation.
Explore other quantum computing companies in similar categories or regions.
Information for Educational Purposes Only: All information about MQS is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of MQS's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.